Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.6K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.6K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration01:25

Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration

236
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
236
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

534
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
534
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

229
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
229
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

363
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
363
Energy-releasing Steps of Glycolysis01:28

Energy-releasing Steps of Glycolysis

147.0K
Glycolysis is divided into two phases based on whether energy is utilized or released. While the first phase consumes ATP, the second phase produces energy in the form of ATP and NADH. The energy is released over a sequence of reactions that turns G3P into pyruvate. The energy-releasing phase—steps 6-10 of glycolysis—occurs twice, once for each of the two 3-carbon sugars produced during steps 1-5 of the first phase.
The first energy-releasing step—the 6th step of glycolysis...
147.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Health professions education in a constrained financing era: implications of the One Big Beautiful Bill Act.

Academic medicine : journal of the Association of American Medical Colleges·2026
Same author

MIC-Drop-seq: scalable single-cell phenotyping of mutant vertebrate embryos.

Nature communications·2026
Same author

Click-to-Release Reactions for Tertiary Amines and Pyridines.

Journal of the American Chemical Society·2026
Same author

Aryl azopyrroles as visible light photoswitchable TRPA1 ligands.

Chemical science·2025
Same author

Combined Inductive and Dispersion Effects Enhance Bioorthogonal Reactivity of Tetrazines Toward Isonitriles.

Angewandte Chemie (International ed. in English)·2025
Same author

An exploratory analysis of 5-alpha reductase inhibitors and risk of opioid use disorder among male Medicare beneficiaries receiving prescription opioid medications.

The American journal on addictions·2025

関連する実験動画

Updated: Feb 8, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.3K

3-イソシアノプロピル群のバイオオートゴナル除去は,バイオでフッ素と薬物の制御された放出を可能にします.

Julian Tu1, Minghao Xu1, Saba Parvez2

  • 1Department of Medicinal Chemistry, College of Pharmacy , University of Utah , 30 S 2000 E , Salt Lake City , Utah 84112 , United States.

Journal of the American Chemical Society
|June 22, 2018
PubMed
まとめ

新しい3イソシアノプロピル基は,生物学的環境で制御された放出のためのマスク剤として作用する. これらのグループは,化学生物学と薬物投与の応用を可能にする様々な機能を迅速に放出します.

さらに関連する動画

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.2K
Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
10:55

Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging

Published on: January 5, 2015

16.7K

関連する実験動画

Last Updated: Feb 8, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
09:11

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release

Published on: February 13, 2016

10.3K
Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
11:02

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction

Published on: September 14, 2018

8.2K
Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging
10:55

Fluorescence-quenching of a Liposomal-encapsulated Near-infrared Fluorophore as a Tool for In Vivo Optical Imaging

Published on: January 5, 2015

16.7K

科学分野:

  • 化学生物学
  • 有機化学
  • 薬物の配達

背景:

  • バイオアクティブ剤の制御された放出には,バイオオートホーガン反応が不可欠です.
  • 既存のマスクグループには 生物学的システムの限界があります

研究 の 目的:

  • 3イソシアノプロピル置換剤をバイオオートホーガン的に放出するための新しいマスクグループとして導入し,評価する.
  • 生理学的な条件下でこれらのグループの効率と生物互換性を実証する.

主な方法:

  • 3イソシアノプロピル誘導体の合成
  • テトラジンとの反応運動の調査.
  • 様々な機能性 (フェノール,アミン) の放出率の評価
  • ゼブラフィッシュの胚をテトラジンで改変したビーズで in vivo 試験した.

主要な成果:

  • 3イソシアノプロピル系はテトラジンと素早く反応して3オキシプロピル系を形成する.
  • フェノールとアミンを含む様々な機能は,生理学的条件下でほぼ定量的に放出されます.
  • ゼブラフィッシュの胚におけるレソルフィン・フッロフォールとメキシレチン薬のイン・ビヴォの放出が成功していることが実証された.

結論:

  • 3イソシアノプロピルの誘導体は 化学的なケージングに多用途で効率的な基盤を提供する.
  • 合成可能なアクセシビリティ,急速な運動能力,および生物適合性により,化学生物学および薬物投与アプリケーションに非常に魅力的です.